Sunzen Biotech Bhd (0148) — Cash Flow Quality Index
Sunzen Biotech Bhd (0148) has a Cash Flow Quality Index of 2.11x as of September 2023. Operating cash flow of RM3.58 Million exceeds net income of RM1.69 Million, indicating high earnings quality where cash backs reported profits. Explore Sunzen Biotech Bhd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sunzen Biotech Bhd Cash Flow Quality Index (2017–2023)
Historical Cash Flow Quality Index for Sunzen Biotech Bhd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 0148 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sunzen Biotech Bhd (2017–2023)
Year-by-year earnings quality comparison for Sunzen Biotech Bhd. For live market cap and the full company financial profile, see 0148 market cap overview.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.12x | RM819.39K | RM6.80 Million | ▲ +101.4% |
| 2022 | -8.55x | RM-32.06 Million | RM3.75 Million | ▲ +64.4% |
| 2021 | -24.05x | RM-16.36 Million | RM680.13K | ▼ -2500.6% |
| 2017 | 1.00x | RM4.02 Million | RM4.01 Million | — |